Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVMED-85 for Pediatric Myopia
NCT05761795Phase 2Not yet recruiting
- Start
- Feb 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of IVMED-85 in myopia. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
IVMED-85
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05761795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05761795.